Lauren S. Kramer

Lauren Kramer advises public and private companies, private equity firms, family offices and sovereign wealth funds in U.S. and cross-border acquisitions, divestitures, mergers, carve-outs, strategic investments and corporate governance matters.

Her select representations include:

• Activision Blizzard Inc. in its pending $75 billion acquisition by Microsoft Corporation;
• Genesys, a portfolio company of the Permira Funds and Hellman & Friedman, in a $580 million round of funding at a valuation of $21 billion;
• Spotify Technology S.A. in its:
  • acquisition of Chartable Holding Inc.; and
  • acquisition of Megaphone LLC from Graham Holdings;
• Honeywell in its $1.3 billion acquisition of Sparta Systems from New Mountain Capital;
• OceanSound Partners and its portfolio company Netrix in the acquisition of the managed IT services business unit of Contegix, LLC;
• American Express Global Business Travel in its acquisition of Ovation Travel Group;
• Vital Proteins in its acquisition by Nestlé Health Science;
• Mubadala Investment Company in its investment as part of a consortium of $2.25 billion in Waymo;
• NXP Semiconductors N.V. in its:
  • $1.8 billion acquisition of Marvell Technology Group Ltd.’s wireless connectivity portfolio; and
  • proposed but terminated $47 billion acquisition by Qualcomm Incorporated;
• Permira Funds in several transactions, including:
  • the sale of its portfolio company LSNE to PCI Pharma Services;
  • its acquisition of a majority stake in Axiom;
  • its acquisition of a majority stake in Reformation;
  • its acquisition of a majority stake in Cielo, Inc. from Accel-KKR;
  • its acquisition of Evonik Jayhawk Fine Chemicals Corporation from Evonik Industries AG; and
  • the $2.3 billion sale of its portfolio company Atrium Innovations to Nestlé S.A.;
• Goldman Sachs & Co. as financial advisor in several transactions, including to:
  • Turning Point Therapeutics, Inc. in its sale to Bristol-Myers Squibb Company for approximately $4.1 billion;
  • Covetrus, Inc. in its sale to funds affiliated with Clayton, Dubilier & Rice and TPG Capital for approximately $4 billion;
  • American Renal Associates Holdings, Inc. in its sale to Innovative Renal Care, LLC, an affiliate of Nautic Partners, LLC, for approximately $853 million; and
  • TRATON SE in its acquisition of Navistar International Corporation for approximately $3.7 billion